APA (7th ed.) Citation

EE, Z., F, N., A, R., P, C., M, R., J, J., . . . D, S. (2024). Interim Effectiveness Estimates of 2024 Southern Hemisphere Influenza Vaccines in Preventing Influenza-Associated Hospitalization - REVELAC-i Network, Five South American Countries, March-July 2024. MMWR. Morbidity and mortality weekly report, 73(39), 861. https://doi.org/10.15585/mmwr.mm7339a1

Chicago Style (17th ed.) Citation

EE, Zeno, et al. "Interim Effectiveness Estimates of 2024 Southern Hemisphere Influenza Vaccines in Preventing Influenza-Associated Hospitalization - REVELAC-i Network, Five South American Countries, March-July 2024." MMWR. Morbidity and Mortality Weekly Report 73, no. 39 (2024): 861. https://doi.org/10.15585/mmwr.mm7339a1.

MLA (9th ed.) Citation

EE, Zeno, et al. "Interim Effectiveness Estimates of 2024 Southern Hemisphere Influenza Vaccines in Preventing Influenza-Associated Hospitalization - REVELAC-i Network, Five South American Countries, March-July 2024." MMWR. Morbidity and Mortality Weekly Report, vol. 73, no. 39, 2024, p. 861, https://doi.org/10.15585/mmwr.mm7339a1.